Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyoshi Yokoi

Showing results (71-80 of 223) with videos related to

Pageof 23
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 5, 2012
Primary percutaneous coronary intervention for acute myocardial infarction in the elderly aged ≥75 yearsKoyu Sakai, Shinya Nagayama, Kasumi Ihara, et al.
The American Journal of Cardiology|March 23, 2002
Comparison of results of coronary angioplasty for acute myocardial infarction in patients > or =75 years of age versus patients <75 years of ageKoyu Sakai, Yoshihisa Nakagawa, Takeshi Kimura, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|November 22, 2008
Efficacy of abciximab for patients undergoing balloon angioplasty: data from Japanese evaluation of c7E3 Fab for elective and primary PCI organization in randomized trial (JEPPORT)Yoshihisa Nakagawa, Masakiyo Nobuyoshi, Tetsu Yamaguchi, et al.
JACC. Cardiovascular Interventions|April 23, 2016
The Characteristics of In-Stent Restenosis After Drug-Eluting Stent Implantation in Femoropopliteal Lesions and 1-Year Prognosis After Repeat Endovascular Therapy for These LesionsOsamu Iida, Mitsuyoshi Takahara, Yoshimitsu Soga, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|December 14, 2011
Long-term outcomes and risk stratification of patency following nitinol stenting in the femoropopliteal segment: retrospective multicenter analysisOsamu Iida, Yoshimitsu Soga, Keisuke Hirano, et al.
Cardiovascular Intervention and Therapeutics|January 19, 2017
Risk of bleeding and repeated bleeding events in prasugrel-treated patients: a review of data from the Japanese PRASFIT studiesMasakatsu Nishikawa, Takaaki Isshiki, Takeshi Kimura, et al.
International Journal of Cardiology|February 14, 2015
Optimal cutoff value of P2Y12 reaction units to prevent major adverse cardiovascular events in the acute periprocedural period: post-hoc analysis of the randomized PRASFIT-ACS studyMasato Nakamura, Takaaki Isshiki, Takeshi Kimura, et al.
Cardiovascular Intervention and Therapeutics|February 13, 2023
Device indication for calcified coronary lesions based on coronary imaging findingsYuji Ikari, Shigeru Saito, Shigeru Nakamura, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 7, 2021
Real-World Clinical Outcomes of IN.PACT Admiral Drug-Coated Balloon for Femoropopliteal Artery Disease - 12-Month Results From Japan Post-Market Surveillance StudyYoshimitsu Soga, Osamu Iida, Masahiko Fujihara, et al.
Journal of Vascular and Interventional Radiology : JVIR|May 17, 2020
Three-Year Efficacy and Safety of the Misago Peripheral Stent for Superficial Femoral Artery Disease: Final Results from the OSPREY TrialJohn F Angle, Alessandro Gasparetto, Hiroyoshi Yokoi, et al.
Pageof 23

Showing results (71-80 of 223) with videos related to

Sort By:
Pageof 23
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 5, 2012
Primary percutaneous coronary intervention for acute myocardial infarction in the elderly aged ≥75 yearsKoyu Sakai, Shinya Nagayama, Kasumi Ihara, et al.
The American Journal of Cardiology|March 23, 2002
Comparison of results of coronary angioplasty for acute myocardial infarction in patients > or =75 years of age versus patients <75 years of ageKoyu Sakai, Yoshihisa Nakagawa, Takeshi Kimura, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|November 22, 2008
Efficacy of abciximab for patients undergoing balloon angioplasty: data from Japanese evaluation of c7E3 Fab for elective and primary PCI organization in randomized trial (JEPPORT)Yoshihisa Nakagawa, Masakiyo Nobuyoshi, Tetsu Yamaguchi, et al.
JACC. Cardiovascular Interventions|April 23, 2016
The Characteristics of In-Stent Restenosis After Drug-Eluting Stent Implantation in Femoropopliteal Lesions and 1-Year Prognosis After Repeat Endovascular Therapy for These LesionsOsamu Iida, Mitsuyoshi Takahara, Yoshimitsu Soga, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|December 14, 2011
Long-term outcomes and risk stratification of patency following nitinol stenting in the femoropopliteal segment: retrospective multicenter analysisOsamu Iida, Yoshimitsu Soga, Keisuke Hirano, et al.
Cardiovascular Intervention and Therapeutics|January 19, 2017
Risk of bleeding and repeated bleeding events in prasugrel-treated patients: a review of data from the Japanese PRASFIT studiesMasakatsu Nishikawa, Takaaki Isshiki, Takeshi Kimura, et al.
International Journal of Cardiology|February 14, 2015
Optimal cutoff value of P2Y12 reaction units to prevent major adverse cardiovascular events in the acute periprocedural period: post-hoc analysis of the randomized PRASFIT-ACS studyMasato Nakamura, Takaaki Isshiki, Takeshi Kimura, et al.
Cardiovascular Intervention and Therapeutics|February 13, 2023
Device indication for calcified coronary lesions based on coronary imaging findingsYuji Ikari, Shigeru Saito, Shigeru Nakamura, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 7, 2021
Real-World Clinical Outcomes of IN.PACT Admiral Drug-Coated Balloon for Femoropopliteal Artery Disease - 12-Month Results From Japan Post-Market Surveillance StudyYoshimitsu Soga, Osamu Iida, Masahiko Fujihara, et al.
Journal of Vascular and Interventional Radiology : JVIR|May 17, 2020
Three-Year Efficacy and Safety of the Misago Peripheral Stent for Superficial Femoral Artery Disease: Final Results from the OSPREY TrialJohn F Angle, Alessandro Gasparetto, Hiroyoshi Yokoi, et al.
Pageof 23